
1 
These Regulations may be cited as the Misuse of Drugs (Amendment) Regulations (Northern Ireland) 1999 and shall come into operation on 1st July 1999.
2 
The Interpretation Act (Northern Ireland) 1954 shall apply to these regulations as it applies to a Measure of the Northern Ireland Assembly.
3 

(1) The Misuse of Drugs (Northern Ireland) Regulations 1986 shall be amended as follows.
(2) In regulation 2(1), after the definition of “document”, there shall be inserted the following definition—“
 “exempt product” means a preparation or other product consisting of one or more component parts, any of which contains a controlled drug, where—
(a) the preparation or other product is not designed for administration of the controlled drug to a human being or animal;
(b) the controlled drug in any component part is packaged in such a form, or in combination with other active or inert substances in such a manner, that it cannot be recovered by readily applicable means or in a yield which constitutes a risk to health; and
(c) no one component part of the product or preparation contains more than one milligram of the controlled drug or one microgram in the case of lysergide or any other N-alkyl derivative of lysergamide;”.
(3) In regulation 4, at the end there shall be added the following paragraph—“
(4) Sections 3(1), 4(1) and 5(1) of the Act shall not have effect in relation to any exempt product.”.
(4) In regulation 14(7), at the end there shall be added the following sub-paragraph—“
(c) any exempt product”.
(5) In regulation 18(2), after sub-paragraph (aa), there shall be inserted the following sub-paragraph—“
(ab) any exempt product;”.
(6) After regulation 24, there shall be inserted the following regulation—“
24A 
Nothing in regulations 19 to 24 shall have effect in relation to any exempt product.”.
Sealed with the Official Seal of the Department of Health and Social Services for Northern Ireland on
W. B. Smith
Assistant Secretary
3rd June 1999.